טוען...
Chronic Lymphocytic Leukemia (CLL) Cells Genetically Modified to Express B7-1, ICAM-1, and LFA-3 Confer APC Capacity to T Cells from CLL Patients
In chronic lymphocytic leukemia (CLL), malignant B cells and nonmalignant T cells exhibit dysfunction. We previously demonstrated that infection of CLL cells with modified vaccinia Ankara (MVA) expressing the costimulatory molecules B7-1, ICAM-1, and LFA-3 (designated TRICOM) increased expression of...
שמור ב:
| Main Authors: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2008
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2664396/ https://ncbi.nlm.nih.gov/pubmed/19009294 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-008-0611-5 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|